Sichuan Otsuka Pharmaceutical

Sichuan Otsuka Pharmaceutical is a joint venture established in 1993 between Japan's Otsuka Pharmaceutical and Chinese partners, headquartered in Chengdu, China. The company focuses on the production and distribution of high-quality pharmaceutical products, including large-volume injections and oral therapeutic medications. Its product portfolio features significant brands such as Pletaal for cardiovascular health, Mucosta for gastrointestinal protection, and Meptin for respiratory conditions. Sichuan Otsuka operates modern manufacturing facilities that comply with stringent GMP standards to ensure product safety and efficacy. As a key component of Otsuka's presence in China, the company plays a vital role in providing clinical nutrition and essential medicines to the regional healthcare system.